Cortisporin Otic Suspension
Neomycin occasionally causes skin sensitization. Ototoxicity and nephrotoxicity have also been reported (see WARNINGS). Adverse reactions have occurred with topical use of antibiotic combinations including neomycin and polymyxin B. Exact incidence figures are not available since no denominator of treated patients is available. The reaction occurring most often is allergic sensitization. In one clinical study, using a 20% neomycin patch, neomycin-induced allergic skin reactions occurred in two of 2,175 (0.09%) individuals in the general population.2 In another study, the incidence was found to be approximately 1%.3
The following local adverse reactions have been reported with topical corticosteroids, especially under occlusive dressings: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae and miliaria. Stinging and burning have been reported rarely when this drug has gained access to the middle ear.
Read the Cortisporin Otic Suspension (neomycin and polymyxin b sulfates and hydrocortisone otic suspension) Side Effects Center for a complete guide to possible side effects
No information provided.
2. Leyden JJ, Kligman AM. Contact dermatitis to neomycin sulfate. JAMA. 1979;242:1276-1278.
3. Prystowsky SD, Allen AM, Smith RW, Nonomura JH, Odom RB, Akers WA. Allergic contact hypersensitivity to nickel, neomycin, ethylenediamine, and ben- zocaine: relationship between age, sex, history of exposure, and reactivity to standard patch and use tests in a general population. Arch Dermatol. 1979;115:959-962.
Last reviewed on RxList: 4/29/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Cortisporin Otic Suspension Information
Cortisporin Otic Suspension - User Reviews
Cortisporin Otic Suspension User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Find out what women really need.